by Peter Ciszewski | Mar 11, 2019
Jennifer McNary is a consultant, speaker, and rare disease advocate. She is also a mother of two boys with Duchenne muscular dystrophy. In this video, Jennifer discusses Rare Disease Day and her evolving role of Advocate to Industry consultant.
by Peter Ciszewski | Mar 9, 2019
Dan O’Connor, President, Director and Chief Executive Officer of OncoSec discusses his company and it’s focus on developing cytokine-based intratumoral immunotherapies to stimulate the body’s immune system to target and attack cancer....
by Peter Ciszewski | Mar 8, 2019
Pushkal Garg, MD, Chief Medical Officer at Alnylam provides an overview of his company and its focus on RNA interference (RNAi). This new class of innovative medicines has the potential to transform the lives of patients who have limited or inadequate treatment...
by Peter Ciszewski | Mar 6, 2019
Armando Anido, Chief Executive Officer at Zynerba Pharmaceuticals discusses his company’s lead product candidate ZYN002, a CBD gel currently being evaluated for Fragile X syndrome. ZTN002 is a pharmaceutically-produced CBD, a non-euphoric cannabinoid,...
by Peter Ciszewski | Mar 4, 2019
James C. Greenwood is President and CEO of the Biotechnology Innovation Organization (BIO) in Washington, DC. BIO represents 1,000 biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States...
